3 results match your criteria: "The Thomas E. Starzl Transplant Institute[Affiliation]"
Am J Transplant
May 2007
Department of Surgery, The Thomas E. Starzl Transplant Institute, Pittsburgh, PA, USA.
The increasing number of candidates for kidney transplantation and relatively unchanged deceased-donor pool has led to expansion in the criteria for donor acceptability. Outcomes of kidneys from donors with progressively rising creatinine values have not been reported. Patients transplanted between September 2003 and August 2006 with kidneys from donors with peak creatinine levels >2.
View Article and Find Full Text PDFAlcohol Clin Exp Res
August 2000
Department of Psychiatry and the Thomas E Starzl Transplant Institute at the University of Pittsburgh Medical Center, Pennsylvania, USA.
Background: Methods to improve assessment, selection, and monitoring of patients with alcoholic cirrhosis who pursue liver transplantation are sought continuously. We chose to investigate the use of the High-Risk Alcohol Relapse (HRAR) scale in our transplant population in the hope that it would improve our ability to identify and follow patients at highest risk for alcohol relapse.
Methods: Detailed alcohol histories of 207 patients evaluated for liver transplantation were collected and graded for severity by using the HRAR.
J Thorac Cardiovasc Surg
April 2000
Departments of Surgery and Pathology and the Thomas E. Starzl Transplant Institute, University of Pittsburgh, PA, USA.
Background: Donor chimerism (the presence of donor cells of bone marrow origin) is present for years after transplantation in recipients of solid organs. In lung recipients, chimerism is associated with a lower incidence of chronic rejection. To augment donor chimerism with the aim to enhance graft acceptance and to reduce immunosuppression, we initiated a trial combining infusion of donor bone marrow with heart transplantation.
View Article and Find Full Text PDF